scholarly journals LB1605 3D imaging of cleared ex vivo normal human skin, skin appendages and psoriasiform skin lesion using light-sheet microscopy

2018 ◽  
Vol 138 (9) ◽  
pp. B23
Author(s):  
C. Jardet ◽  
S. Abadie ◽  
M. Pastore ◽  
J. Colombelli ◽  
B. Chaput ◽  
...  
2018 ◽  
Vol 24 (2) ◽  
pp. 294-303 ◽  
Author(s):  
S. Abadie ◽  
C. Jardet ◽  
J. Colombelli ◽  
B. Chaput ◽  
A. David ◽  
...  

1996 ◽  
Vol 106 (3) ◽  
pp. 283-289 ◽  
Author(s):  
W. K. F. Seelentag ◽  
Ursula Günthert ◽  
Parvin Saremaslani ◽  
E. Futo ◽  
Madeleine Pfaltz ◽  
...  

1987 ◽  
Vol 279 (8) ◽  
pp. 550-557 ◽  
Author(s):  
A. Tsubura ◽  
S. Morii ◽  
S. Ueda ◽  
M. Sasaki ◽  
St. Zotter ◽  
...  

1996 ◽  
Vol 106 (3) ◽  
pp. 283-289 ◽  
Author(s):  
Walter K. F. Seelentag ◽  
Ursula Günthert ◽  
Parvin Saremaslani ◽  
Eva Futo ◽  
Madeleine Pfaltz ◽  
...  

1984 ◽  
Vol 12 (2) ◽  
pp. 89-97
Author(s):  
Graham R. Elliott ◽  
H.E. Amos ◽  
James W. Bridges

The rate of growth of normal human skin fibroblasts was inhibited in a dose related, reversible, fashion by practolol (N-4-(2-hydroxy)-3 (1-methyl)-aminopropoxyphenylacetamine) (ID50 1.35 ± 0.14 x 10-3M), propranolol (1-(isopropylamino)-3(1-naphthyl-oxy)-2-propranolol) (ID50 0.145 ± 0.02 x 10-3M) and paracetamol (N-(4-hydroxyphenyl) acetamide) (ID50 0.85 ± 0.2 x 10-3M). Skin fibroblasts isolated from a psoriasis patient were more sensitive towards practolol (ID50 0.48 ± 0.14 x 10-3M) and propranolol (ID50 0.032 ± 0.002 x 10-3M), but less sensitive towards paracetamol (ID50 1.3 ± 0.07 x 10-3M). In vitro generated metabolites of practolol, using normal or Arochlor 1254-pretreated hamster liver preparations, and structural analogues of practolol had no effect upon the growth of either cell type.


1987 ◽  
Vol 117 (4) ◽  
pp. 419-428 ◽  
Author(s):  
C.R. LOVELL ◽  
K.A. SMOLENSKI ◽  
V.C. DUANCE ◽  
N.D. LIGHT ◽  
S. YOUNG ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document